Dr
Andrew
Wells

Partner & Head of Chemistry

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 752 507 1499
Email. [email protected]

Experience

Andrew’s patent practice is principally in the pharmaceutical and chemical fields. He has extensive experience in securing patent protection for pharmaceuticals and specialises in drafting and prosecuting patent applications covering new chemical entities, salts, polymorphs, formulations (including advanced drug delivery technologies), manufacturing processes, medical uses, and medical devices. Outside of the pharmaceutical field, Andrew’s practice encompasses agrochemicals, polymer chemistry, petroleum additives, catalytic compositions, separation chemistry, adhesive technologies and biosensors.

Andrew acts for a diverse range of clients, including international corporations, universities, start-up companies and associate patent attorney firms based outside of the UK.

He commenced his patent career in private practice before joining the in-house patent department of a major multi-national pharmaceutical company in June 2004. As an in-house attorney, Andrew was responsible for the patent portfolios relating to a number of high priority drug development projects, as well as conducting IP due diligence evaluations to support in-licensing activities. Andrew returned to private practice in November 2008 when he joined the Manchester office of HGF as a Partner.

Andrew draws on both his private practice and in-house experience to provide commercially-focused advice to his clients in relation to all patent matters, including patent portfolio management, enforcing patent rights, challenging third party patent rights, providing infringement and validity opinions, and conducting due diligence evaluations to support licensing and acquisition deals. Andrew also has considerable experience in representing clients in opposition and appeal proceedings at the European Patent Office.

Specialisms

  • Catalysis
  • Material science
  • Pharmaceutical technologies
  • Polymer chemistry

Industries

  • Agrochemicals icon Agrochemicals
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • In-house legal support
  • Patent oppositions & appeals
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


OTHER

BPharm

PHD

The development and evaluation of microparticulate formulations for DNA immunisation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property Law

Recognition

IAM Strategy 300 - Leading IP Strategists

Andrew is listed in the IAM Strategy 300 as a leading IP strategist

View recognition online

IAM Patent 1000

Andrew is listed in the IAM Patent 1000 as a leading IP attorney in his field.

View recognition online

MIP Star

Andrew is listed as a MIP Star.

View recognition online

Publications

Drug repurposing: progress, challenges and recommendations - Nature Medicine article on Drug Repurposing

View publication online

CSR

Andrew mentors and contributes to the professional training of Trainee Patent Attorneys within HGF, as well as mentoring and training of IP and technology transfer professionals in other organisations.

Related News

Decision of the EBoA regarding G1/21

Oral proceedings by videoconference can be enforced by the EPO during the pandemic On 16 July 2021 the EPO’s Enlarged Board of Appeal (EBoA) decided on referral G 1/21 regarding …

Read article
Event - 29th July 2021

HGF and Shiga webinar: Patenting sports and fitness technology in Europe and Japan

HGF in Europe and Shiga in Japan are holding a joint webinar on 29th July 2021. Fitter, faster, stronger – patenting sports and fitness technology in Europe and Japan Sporting …

Event details

IAM Patent 1000 2021

The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …

Read article
Event - 20th July 2021

WIPR Patents Live webinar: Protecting medical devices in Europe—avoiding common pitfalls

WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in …

Event details

G1/21 hearing at the EPO - July

G1/21 hearing continues on 2nd July 2021. Follow this page for updates from HGF Partner Douglas Drysdale and Patent Director Ellie Purnell, who will be reporting all the key moments …

Read article
Event - 13th July 2021

Webinar: Patents for the offshore sector

HGF is hosting a ‘Patents for the offshore sector’ webinar on 13th July, 2021. The webinar will be presented by HGF Patent Director Richard Gover. It will include an introduction …

Event details

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.